Category: Advances in IBD
Monitoring for Postoperative Recurrence of Crohn’s Disease
G&H Why is monitoring for postoperative recurrence of Crohn’s disease important? NKC The risk of postoperative recurrence of Crohn’s disease is incredibly high. Population-based studies have […]
Early Intervention in Crohn’s Disease
G&H What biologic features of Crohn’s disease support the rationale for early intervention? BS Crohn’s disease is a chronic, progressive, transmural inflammatory disease in which ongoing […]
Differences in Inflammatory Bowel Disease Across Ethnicities and Racial Groups
G&H What is the prevalence of inflammatory bowel disease across ethnicities and racial groups in the United States? OD Data from the National Health Interview Survey […]
JAK Inhibitor–Associated Acne in IBD: Recognition and Management
G&H How often does acne develop in inflammatory bowel disease patients treated with Janus kinase inhibitors? BC Acne is most commonly associated with the Janus kinase […]
When Should Pediatric Inflammatory Bowel Disease Patients Be Allowed to Take Approved Therapies for Adults?
G&H If an inflammatory bowel disease therapy works for adults, can it be extrapolated that the therapy may also work for adolescents and children? MK Extrapolation […]
Mitigating the Adverse Effects of Poor Nutritional Status in the Management of Adult Patients With Crohn’s Disease
G&H How much impact do poor nutritional status and inadequate nutrition therapy have on adult patients with Crohn’s disease? SM Malnutrition has an adverse effect on […]
Inflammatory Bowel Disease and Eosinophilic Esophagitis
G&H Do patients with inflammatory bowel disease have a higher risk of eosinophilic esophagitis? EB Several single-center studies have shown that patients with inflammatory bowel disease […]
Pouch Surveillance: The Bottom Line
G&H What are the arguments for and against pouch surveillance? SH First of all, it should be kept in mind that although total proctocolectomy with ileoanal […]
Insights Into Colonoscopic Surveillance for Dysplasia in Inflammatory Bowel Disease
G&H How has colonoscopic imaging evolved? JL The major change that has occurred is improvement in the optics of colonoscopes. Providers used to be accustomed to […]
Anastomoses for Ileocolonic Resection in Patients With Crohn’s Disease
G&H What are the most common types of anastomoses currently being used for ileocolonic resection in Crohn’s disease? FM There are currently 4 types of anastomoses. […]
Exploring the Potential of TL1A Inhibition in the Treatment of Inflammatory Bowel Disease Patients
G&H How does tumor necrosis factor-like ligand 1A differ from tumor necrosis factor? ST In 2002, my colleagues at Cedars-Sinai and I discovered the expression of […]
Prehabilitation for Inflammatory Bowel Disease Surgery
G&H What is the rationale for prehabilitation for inflammatory bowel disease surgery? JA Prehabilitation is good for almost any type of surgery, not just inflammatory bowel […]
How to Approach Immune Checkpoint Inhibitor Enterocolitis
G&H What are the similarities and differences between immune checkpoint inhibitor enterocolitis and inflammatory bowel disease in terms of etiology, clinical presentation, and endoscopic presentation? YW […]
Current Status of Fecal Microbiota Transplantation for Inflammatory Bowel Disease Management
G&H Based on the research to date, does fecal microbiota transplantation show promise for the treatment of ulcerative colitis? JA Yes, although there is still a […]
Treating Patients With Inflammatory Bowel Disease During and After Cancer
G&H What is the risk of cancer in patients with inflammatory bowel disease? JA Individuals with inflammatory bowel disease (IBD) are at an increased risk of […]
Insights Into Cell Therapies for Patients With Inflammatory Bowel Disease
G&H Why has there been interest in using cell therapies to treat patients with inflammatory bowel disease? LC For a long time, it seemed like it […]
What Is Moderate to Severe Inflammatory Bowel Disease?
G&H Why is it important to define moderate to severe inflammatory bowel disease? LP-B It is very important to define moderate to severe inflammatory bowel disease […]
Use of Interleukin-23 Inhibitors for the Treatment of Inflammatory Bowel Disease
G&H Why did interleukin-23 inhibition become a treatment approach for inflammatory bowel disease? EL There are several reasons. One is that overexpression of interleukin (IL)-23 has […]
Management of Patients With Refractory Ulcerative Proctitis
G&H What is the current understanding of the relationship between ulcerative proctitis and ulcerative colitis? MC Ulcerative proctitis is part of the disease spectrum of ulcerative […]
Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Inflammatory Bowel Disease
G&H How prevalent are obesity and overweight in patients with inflammatory bowel disease, and how can these conditions affect this patient population? CB With the global […]